Home > Products > Biosimilars

BioSIM anti-Human TNF-α Antibody (Infliximab Biosimilar), Research Grade

Catalog: SIM0022
Cost advantage to: SIM0006
Isotype: IgG1-kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic biosimilar uses Infliximab’s variable regions, ideal for research. It binds human TNFα (a multifunctional proinflammatory cytokine—soluble/membrane-bound, TNF superfamily, receptors TNFR1/TNFR2). TNFα, mainly from macrophages, aids key biological processes; its dysregulation links to diseases. Infliximab blocks TNFα-receptor interaction, downregulating autoimmune-related inflammation.
 

Specifications

Product Name BioSIM anti-Human TNF-α Antibody (Infliximab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG1-kappa
Target TNF-α
Other Names TA-650, cA2, CAS: 170277-31-3
CAS 170277-31-3
Reactivity Human
Host Species Chimeric
Background This non-therapeutic biosimilar uses Infliximab’s variable regions, ideal for research. It binds human TNFα (a multifunctional proinflammatory cytokine—soluble/membrane-bound, TNF superfamily, receptors TNFR1/TNFR2). TNFα, mainly from macrophages, aids key biological processes; its dysregulation links to diseases. Infliximab blocks TNFα-receptor interaction, downregulating autoimmune-related inflammation.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products